Results 141 to 150 of about 826 (152)
Some of the next articles are maybe not open access.

Preservativos e infección por papilomavirus

FMC - Formación Médica Continuada en Atención Primaria, 2007
Carles Llor, Carolina Bayona
openaire   +1 more source

Papilomavirus humano y carcinomas cutáneos

Piel, 2010
Antonio Rodríguez Pichardo   +1 more
openaire   +1 more source

Charakterizace virových nanočástic odvozených od myšího papilomaviru

2019
The L1 and L2 capsid proteins of papillomaviruses are characterized by the ability to self- assemble into viral capsids, which can be divided into pseudovirions (PsVs) and virus-like particles (VLPs) by inner content. In addition to the fact that such particles can serve as "nano-containers" for diagnostic and therapeutic agents, it has also been shown
openaire   +1 more source

Prevención de la infección por papilomavirus humano

FMC - Formación Médica Continuada en Atención Primaria, 2023
Cruz Bartolomé-Moreno   +1 more
openaire   +1 more source

AÇÕES IMUNOLÓGICAS INDUZIDAS PELO PAPILOMAVIRUS HUMANO

Anais do III Congresso Brasileiro de Imunologia On-line, 2023
openaire   +1 more source

Virus del papiloma humano (papilomavirus)

Progresos de Obstetricia y Ginecología, 2001
openaire   +1 more source

Heterologní exprese onkoproteinu E7 lidského papilomaviru (HVP 16)

2010
Production of vaccines and pharmaceutical proteins in plants is a promising nascent technology with a great potential to provide high-quality, safe and non-expensive production and delivery platform. In this work we studied the experimental vaccine against human papillomavirus based on modified plant pathogen - Potato virus X (PVX).
openaire   +1 more source

Cellular transformation by papilomavirus oncorproteins

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993
C P, Mansur, E J, Androphy
openaire   +2 more sources

Home - About - Disclaimer - Privacy